Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents.

Cacoub P, Commarmond C, Sadoun D, Desbois AC

Open source

DOI
10.1016/j.rdc.2016.09.011
Published
2017 Feb
Container
Rheumatic diseases clinics of North America
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rdc.2016.09.011,
  title = {Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents.},
  author = {Cacoub P and Commarmond C and Sadoun D and Desbois AC},
  year = {2017},
  journal = {Rheumatic diseases clinics of North America},
  doi = {10.1016/j.rdc.2016.09.011},
  url = {https://doi.org/10.1016/j.rdc.2016.09.011}
}

RIS

TY  - JOUR
TI  - Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents.
AU  - Cacoub P
AU  - Commarmond C
AU  - Sadoun D
AU  - Desbois AC
PY  - 2017
JO  - Rheumatic diseases clinics of North America
DO  - 10.1016/j.rdc.2016.09.011
UR  - https://doi.org/10.1016/j.rdc.2016.09.011
ER  - 

APA

P, C., C, C., D, S., & AC, D. (2017). Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents.. Rheumatic diseases clinics of North America. https://doi.org/10.1016/j.rdc.2016.09.011

Source records